<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38532037</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-7209</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>May</Month></PubDate></JournalIssue><Title>Angiogenesis</Title><ISOAbbreviation>Angiogenesis</ISOAbbreviation></Journal><ArticleTitle>Connective tissue disorders in COVID-19: Reply to "People with a connective tissue disorder may be especially vulnerable to the endothelial damage that characterizes long COVID due to the fragility of their vasculature and slow wound healing".</ArticleTitle><Pagination><StartPage>125</StartPage><EndPage>127</EndPage><MedlinePgn>125-127</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10456-024-09915-x</ELocationID><Abstract><AbstractText>Connective tissue serves as a framework for other tissues and organs, supporting their functions, shielding them from harmful factors, and aiding repair. In COVID-19, damaged endothelial cells (ECs), increased endothelial permeability, and thrombi contribute to the connective tissue disorders. Even post-recovery, the damage to ECs and connective tissues persists, resulting in long COVID. Individuals with connective tissue disorders are prone to developing severe COVID-19 and experiencing long COVID symptoms. It is advised that these patients receive at least three vaccine doses, undergo early prophylactic antithrombotic therapy during acute COVID-19, and maintain prophylactic anticoagulant treatment in cases of long COVID.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s), under exclusive licence to Springer Nature B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Xiaoming</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Hematology, The First Hospital, Harbin Medical University, Harbin, 150001, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Key Laboratory of Myocardial Ischemia, Harbin Medical University, Ministry of Education Harbin, Harbin, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Basic Medical Sciences, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Novakovic</LastName><ForeName>Valerie A</ForeName><Initials>VA</Initials><AffiliationInfo><Affiliation>Department of Research, Harvard Medical School, VA Boston Healthcare System, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Jialan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-5642-5436</Identifier><AffiliationInfo><Affiliation>Department of Hematology, The First Hospital, Harbin Medical University, Harbin, 150001, China. jialan_shi@dfci.harvard.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Research, Harvard Medical School, VA Boston Healthcare System, Boston, MA, USA. jialan_shi@dfci.harvard.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA. jialan_shi@dfci.harvard.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Angiogenesis</MedlineTA><NlmUniqueID>9814575</NlmUniqueID><ISSNLinking>0969-6970</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014945" MajorTopicYN="Y">Wound Healing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042783" MajorTopicYN="N">Endothelial Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003238" MajorTopicYN="N">Connective Tissue</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>17</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>27</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38532037</ArticleId><ArticleId IdType="doi">10.1007/s10456-024-09915-x</ArticleId><ArticleId IdType="pii">10.1007/s10456-024-09915-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ (2023) Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 21(3):133&#x2013;146. https://doi.org/10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId><ArticleId IdType="pmc">9839201</ArticleId></ArticleIdList></Reference><Reference><Citation>Hidalgo A, Libby P, Soehnlein O, Aramburu IV, Papayannopoulos V, Silvestre-Roig C (2022) Neutrophil extracellular traps: from physiology to pathology. Cardiovasc Res 118(13):2737&#x2013;2753. https://doi.org/10.1093/cvr/cvab329</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvab329</ArticleId><ArticleId IdType="pubmed">34648022</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y, Lin CH, Chen JY, Li CH, Liu YT, Chen BC (2016) Induction of connective tissue growth factor expression by hypoxia in human lung fibroblasts via the MEKK1/MEK1/ERK1/GLI-1/GLI-2 and AP-1 pathways. PLoS ONE 11(8):e0160593. https://doi.org/10.1371/journal.pone.0160593</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0160593</ArticleId><ArticleId IdType="pubmed">27486656</ArticleId><ArticleId IdType="pmc">4972311</ArticleId></ArticleIdList></Reference><Reference><Citation>Awosanya OD, Dadwal UC, Imel EA, Yu Q, Kacena MA (2022) The impacts of COVID-19 on musculoskeletal health. Curr Osteoporos Rep 20(4):213&#x2013;225. https://doi.org/10.1007/s11914-022-00734-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11914-022-00734-x</ArticleId><ArticleId IdType="pubmed">35723777</ArticleId><ArticleId IdType="pmc">9207429</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M, Wang L, Wang M, Zhou S, Lu Y, Cui H, Racanelli AC, Zhang L, Ye T, Ding B, Zhang B, Yang J, Yao Y (2022) Targeting fibrosis: mechanisms and clinical trials. Signal Transduct Target Ther 7(1):206. https://doi.org/10.1038/s41392-022-01070-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-01070-3</ArticleId><ArticleId IdType="pubmed">35773269</ArticleId><ArticleId IdType="pmc">9247101</ArticleId></ArticleIdList></Reference><Reference><Citation>Spagnolo P, Cordier JF, Cottin V (2016) Connective tissue diseases, multimorbidity and the ageing lung. Eur Respir J 47(5):1535&#x2013;1558. https://doi.org/10.1183/13993003.00829-2015</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00829-2015</ArticleId><ArticleId IdType="pubmed">26917611</ArticleId></ArticleIdList></Reference><Reference><Citation>Machado PM, Lawson-Tovey S, Strangfeld A, Mateus EF, Hyrich KL, Gossec L, Carmona L, Rodrigues A, Raffeiner B, Duarte C et al (2022) Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry. Ann Rheum Dis 81(5):695&#x2013;709. https://doi.org/10.1136/annrheumdis-2021-221490</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2021-221490</ArticleId><ArticleId IdType="pubmed">34972811</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippini F, Giacomelli M, Bazzani C, Fredi M, Semeraro P, Tomasi C, Franceschini F, Caruso A, Cavazzana I, Giagulli C (2023) Efficacy of COVID-19 mRNA vaccination in patients with autoimmune disorders: humoral and cellular immune response. BMC Med 21(1):210. https://doi.org/10.1186/s12916-023-02868-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-023-02868-w</ArticleId><ArticleId IdType="pubmed">37316832</ArticleId><ArticleId IdType="pmc">10266318</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. COVID-19 Treatment Guidelines. https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>